Shares of Danone closed down 2.28% on the Paris exchange this Monday, January 27, 2026, after recording an intraday drop of more than 6%. The retreat occurred in response to the expansion of the preventive recall of batches of infant formula due to the risk of the presence of cereulide toxin. The French company adopted the measure in line with guidelines from regulatory authorities in several countries.
The sectoral crisis has gained strength in recent weeks, initially with Nestlé, and now also reaching Danone and Lactalis. Nenhum confirmed case of illness in babies has been directly associated with Danone products to date. The company reinforced that the recall is preventive in nature and covers limited volumes.
The market reacted immediately to the announcement of the expansion of the recall. Analistas point out that the episode reinforces investors’ concerns about the supply chain in the infant nutrition sector.
Details of the recall announced by the company
Danone reported that it withdrew specific batches of infant formula produced for certain markets. The decision followed detection of traces of the toxin cereulide in tests carried out by authorities in Singapura, where a batch was initially blocked.
The company expanded the measure to other countries on a voluntary basis. Affected products include variations of the Aptamil line and other specialty baby nutrition brands. Danone highlighted that the potential contamination occurred in a raw ingredient shared with other manufacturers.
Immediate impact on stock performance
Danone shares opened the trading session with a significant drop and reached their lowest level since January 2025 in the morning. Trading volume has increased considerably compared to the recent average.
At the end of the day, the stock recovered part of the losses, but still closed in negative territory. The movement followed a similar trend observed in other giants in the dairy sector that face similar recalls.
Context of cereulide toxin in the sector
Cereulide is a toxin produced by the bacteria Bacillus cereus and resists high temperatures. Sua presence in infant formulas raises alarms because babies’ digestive systems are more vulnerable.
Health authorities in several countries intensified tests on products in the segment after the first cases were detected. The substance can cause vomiting and other gastrointestinal symptoms, although there are no confirmed records of poisoning related to batches of Danone.
Industry experts monitor the evolution of regulatory investigations. The current crisis exposes challenges in ensuring complete safety in large-scale production of food for newborns.
Measures adopted by Danone
The French company has temporarily suspended the distribution of suspicious batches in all affected markets. Equipes internal companies carry out additional audits on the raw material suppliers involved.
Danone announced that it maintains constant dialogue with regulatory agencies. The company also provided guidance to retailers and consumers on return procedures for recalled products.
- Immediate suspension of distribution of identified lots
- Voluntary extension of the recall beyond initial requirements
- Reinforcement of incoming ingredient testing protocols
- Direct communication with local health authorities
Financial market reactions
Investment banking analysts have revised short-term projections for Danone. Parte of the assessments indicates a risk of marginal impact on annual sales of infant nutrition.
The segment represents a relevant portion of the company’s global revenue. Investidores monitor possible effects in other markets where the brand has a strong presence.
Countries involved in the recall
The Danone recall initially covers Singapura, where the problem was identified by local authorities. The measure was later extended to other selected Asian and European markets.
The company has not released a full list of affected countries to avoid unnecessary confusion. Consumidores receive guidance to check batch numbers on purchased packages.
Recent safety history in the segment
The infant formula sector has gone through similar episodes in recent years in different regions. Fabricantes implemented additional layers of control following previous recalls involving bacterial contamination.
Danone continually invests in production chain traceability technologies. The company maintains international quality certifications in its production units.
Official positioning of the company
Danone executives reiterated their priority commitment to consumer safety. The company stated that no batch with confirmed detection of levels above the limits was sold.
Additional independent tests are ongoing. Danone provided specific channels for queries from parents and health professionals.
Effects observed on competitors
Nestlé, a pioneer in recall announcements this month, also recorded volatility in its shares. The same pattern was repeated with the Lactalis in European markets.
The collective episode puts pressure on the entire child nutrition segment. Reguladores discuss possible updates to production and monitoring standards.
The current crisis demonstrates interconnectedness between global ingredient suppliers. Fabricantes review contracts and technical specifications to mitigate future risks.
Perspective from food safety experts
Professionals in the field highlight the importance of early detection of heat-resistant contaminants. Cereulide requires specific laboratory analysis methods.
Agencies such as Agência of Normas Alimentares of Reino Unido issued coordinated alerts. Países members of União Europeia have aligned rapid response procedures.
Estimated volume of collected lots
Danone classified the affected volume as limited in relation to total production. Batches represent a small fraction of annual global formula sales.
The company did not disclose exact numbers of recalled units. The focus remains on completely removing the identified products from the shelves.
The preventive recall avoids potential consumer exposure. Danone absorbs logistics and replacement costs associated with the operation.
Continuous monitoring by authorities
Regulatory bodies maintain active surveillance over the development of the situation. Additional Testes occurs in samples from different manufacturers.
There is no evidence of systemic contamination in the industry so far. Casos remain restricted to specific batches from a few suppliers.